Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xiaoliuping
- Development stage
- Unknown
- Lead developer
- Jiangxi Sanqi Bioengineering
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiaoliuping is a botanical drug candidate developed by Jiangxi Sanqi Bioengineering Co., Ltd. for the treatment of advanced non-small cell lung cancer (NSCLC). It is formulated as an oral tablet and has been investigated in clinical trials as a monotherapy for patients with stage IV NSCLC following the completion of chemotherapy. The drug is intended to improve clinical symptoms and safety outcomes in this patient population. As a traditional Chinese medicine-derived formulation, its therapeutic approach likely involves multi-target effects on the tumor microenvironment and immune system, although specific molecular targets have not been publicly disclosed.
- Brand names
- Xiaoliu Ping
- Other names
- Xiaoliu PingXiaoliuping tablets
02
Targets
BAX (Apoptosis regulator BAX)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on xiaoliuping.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xiaoliuping.